Inocras
Highly Engaged Employees
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6330 Nancy Ridge Dr Ste 106, San Diego, ...Phone Number
+852 35116347Website
www.inocras.comRevenue
$7 MillionIndustry
About Inocras
Inocras Org Chart
Is Inocras your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Inocras has recently received funding, and reach out quickly before it becomes old news!
Click to see if Inocras had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Inocras is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Inocras
Funding: Get notified immidiatlly once Inocras has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Inocras recently announced quarterly report
Inocras, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Inocras launches new products
Recommended Actions
Find VP level buyers at Inocras
Find 3 more new buyers
Company Profile Activity
Activity Insights
Inocras is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Inocras is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Inocras.
Inocras News & Media
ChiMei Medical Center adopts Inocras MRDVision and WGS bioinformatics platform for precision oncology in Taiwan
SAN DIEGO & TAINAN CITY, Taiwan--(BUSINESS WIRE)--Inocras Inc., a global leader in whole-genome sequencing (WGS) and bioinformatics, today announced the signing of a Memorandum of Understanding (MOU) with ChiMei Medical Center (CMMC), a premier medical institution in Taiwan, and Trivator Biomedical Limited, a biomedical advisory firm in Taiwan. This expansion agreement aims to introduce Inocras’s MRDVision tumor-informed minimal residual disease (MRD) test, utilizing circulating tumor DNA (ctDNInocras and Center for Data Driven Discovery in Biomedicine Enter Collaborative Research Agreement to Advance Sinonasal Cancer Research
SAN DIEGO--(BUSINESS WIRE)--Today, Inocras announced the signing of a groundbreaking Collaborative Research Agreement with the Center for Data Driven Discovery in Biomedicine (D3b) to advance research into rare sinonasal cancers. Under the agreement, Inocras will conduct Whole Genome Sequencing (WGS) and bioinformatic analysis on rare sinonasal cancer samples provided by D3b. The leadership team at the Center for Data Driven Discovery in Biomedicine (D3b) - Phillip “Jay” Storm, Adam Resnick, anFore Genomics Partners with Inocras to Launch Pediatric Genetic Health Screening and Newborn Sequencing
SAN DIEGO--(BUSINESS WIRE)--Today, Fore Genomics, a leader in pediatric genetic health screening, announced a strategic partnership with Inocras, a leading innovator in whole genome sequencing (WGS) and AI-powered genetic analysis technologies, to enhance Fore’s proprietary pediatric and newborn health screening services. This collaboration marks a significant step towards improving early detection and intervention for a large number of pediatric-onset genetic conditions, with the initial rollo
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inocras
Founded in 2020 by a team of physician-scientists, geneticists, and bioinformaticians, the company's goal has been to improve how patients are diagnosed and treated by unlocking the full potential of genomic data. Since then, weve developed an IP-protected technology and proprietary whole genome insight platform while achieving operational excellen... Read More

